Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2011-11-17

FDA Approved: LEVETIRACETAM — Supplemental Application (Patrin Pharma, Inc.)

View source ↗

Summary

FDA approved a supplemental application for Levetiracetam from Patrin Pharma, Inc., resulting in a supplemental approval for this generic anticonvulsant. The ap…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LEVETIRACETAM (levetiracetam)

Snippet

SUPPL AP for LEVETIRACETAM (LEVETIRACETAM)